D
AC Immune SA ACIU
$3.13 -$0.02-0.64% NASDAQ
Recommendation
Prev Close
$3.13
Volume
159,208
Avg Vol (90D)
530,606
Market Cap
$309.69M
Dividend & Yield
--
52-Week Range
$1.43 - $4.00
P/E (TTM)
--
EPS (TTM)
-$0.59
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
AC Immune SA (ACIU, $3.18) price moved above its 50-day Moving Average on December 22, 2025
12/23/2025 - Tickeron - Technical Analysis
AC Immune (NASDAQ:ACIU) Trading Up 5% - Should You Buy?
12/23/2025 - MarketBeat
AC Immune (NASDAQ:ACIU) Trading Up 5% - Should You Buy?
12/23/2025 - Zolmax
AC Immune: Maintaining 'Buy' Rating On Next Steps For ACI-7104.056 Development In PD
12/15/2025 - SeekingAlpha
AC Immune: Maintaining 'Buy' Rating On Next Steps For ACI-7104.056 Development In PD
12/15/2025 - Seeking Alpha - Long Ideas
AC Immune SA (ACIU, $3.22) Moving Average Convergence Divergence (MACD) Histogram turned positive on December 11, 2025
12/12/2025 - Tickeron - Technical Analysis
AC Immune SA (ACIU, $3.22) price may drop as it broke higher Bollinger Band on Dec 11, 2025
12/12/2025 - Tickeron - Technical Analysis
AC Immune SA (ACIU, $3.22) Stochastic Oscillator left the oversold zone on December 11, 2025
12/12/2025 - Tickeron - Technical Analysis
Why Is AC Immune Stock Up Over 23% Today?
12/11/2025 - Stocktwits News Feed
AC Immune surges on positive mid-stage trial data for Parkinson's drug
12/11/2025 - Seeking Alpha - Healthcare
AC Immune (ACIU) Reports Encouraging Phase 2 Results for Parkinson's Therapy
12/11/2025 - GuruFocus
AC Immune's Parkinson's disease candidate shows positive Phase 2 results
12/11/2025 - The Fly
AC Immune Positive Interim Phase 2 Data on ACI-7104. ...
12/11/2025 - GuruFocus
AC Immune Positive Interim Phase 2 Data on ACI-7104.056 Support Potential Slowing of Progression of Parkinson's Disease
12/11/2025 - Globe Newswire
AC Immune SA's (NASDAQ:ACIU) stock price dropped 11% last week; retail investors would not be happy
12/10/2025 - Simply Wall St
AC Immune SA (ACIU, $3.05) price may climb as it broke lower Bollinger Band on Nov 18, 2025
11/19/2025 - Tickeron - Stocks
AC Immune SA (ACIU, $3.05) price exceeded its 50-day Moving Average on November 18, 2025
11/19/2025 - Tickeron - Stocks
AC Immune SA (ACIU, $3.39) Stochastic Oscillator left the oversold zone on November 11, 2025
11/12/2025 - Tickeron - Stocks
AC Immune SA (ACIU, $3.35) entered Downtrend as Momentum indicator drops below 0 level on Nov 10, 2025
11/11/2025 - Tickeron - Stocks
AC Immune to Present at the Jefferies 2025 London Healthcare Conference
11/11/2025 - GuruFocus
AC Immune to Present at the Jefferies 2025 London Healthcare Conference
11/11/2025 - Globe Newswire
FY2025 EPS Estimates for AC Immune Lifted by HC Wainwright
11/8/2025 - MarketBeat
FY2025 EPS Estimates for AC Immune Raised by Leerink Partnrs
11/8/2025 - MarketBeat
AC Immune (NASDAQ:ACIU) Earns "Buy" Rating from BTIG Research
11/5/2025 - MarketBeat
AC Immune (NASDAQ:ACIU) Issues Earnings Results
11/5/2025 - MarketBeat
Income Statement
Total Revenue (TTM)
$33.44M
EBITDA (TTM)
-$56.18M
EBIT (TTM)
-$57.85M
Net Income (TTM)
-$58.48M
Balance Sheet
Total Assets (Q)
$239.19M
Total Debt (Q)
$6.19M
Total Liabilities (Q)
$145.21M
Book Value Per Share (Q)
$0.9339
Cash Flow
Cash from Operations (TTM)
-$49.43M
Cash from Investing (TTM)
$25.55M
Cash from Financing (TTM)
-$1.01M
Net Change in Cash (TTM)
-$28.91M
Filings
Filing Date
Tuesday, August 5, 2025
Period Date
Monday, June 30, 2025
Next Filing
(est)
Price History
Loading...
Beta
1.16
7-Day Total Return
-4.86%
30-Day Total Return
-4.57%
60-Day Total Return
2.96%
90-Day Total Return
52.68%
Year to Date Total Return
9.82%
1-Year Total Return
15.71%
2-Year Total Return
-33.97%
3-Year Total Return
79.89%
5-Year Total Return
-41.60%
52-week Low
Apr 09, 2025 - $1.43
52-week High
Oct 29, 2025 - $4.00
Valuation
Market Cap
$309.69M - Small Cap
Enterprise Value
$179.51M
Price/Sales (TTM)
9.42
Price/Book (Q)
3.35
Dividends and Shares
Shares Outstanding
100.63
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.acimmune.com
Phone Number
41 21 345 91 21
Address
Building B
Lausanne, 1015
Country
Switzerland
Year Founded
2003
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines, and therapeutic and diagnostic products for the prevention and treatment of neurodegenerative... more
NASDAQ 12/24/2025 1:00PM Eastern Quotes delayed